Gut-Brain-Axis Therapeutics
Gut-Brain-Axis Therapeutics is a startup headquartered in Tempe, United States, founded in 2022. It has raised at least $3.4m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Gut-Brain-Axis Therapeutics has raised at least $3.4m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Gut-Brain-Axis Therapeutics sits inside the Phoenix region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Tempe
Related
- Innovation profile of Tempe
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Gut-Brain-Axis Therapeutics do?
Gut-Brain-Axis Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Gut-Brain-Axis Therapeutics raised?
At least $3.4m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Gut-Brain-Axis Therapeutics based?
Gut-Brain-Axis Therapeutics is headquartered in Tempe, United States.
When was Gut-Brain-Axis Therapeutics founded?
Gut-Brain-Axis Therapeutics was founded in 2022.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.